Pharma Times

AUGUST 7, 2020

Scientists from the University of Oxford say the drug is being ‘discarded prematurely’

169

169

pharmaphorum

AUGUST 5, 2020

The UK government has asked pharma companies to build a six-week stockpile of drugs and find alternative shipping routes to the congested Dover-Calais crossing as the country heads for Brexit at the end of the year. In a letter , Steve Oldfield, chief commercial officer at the Department of Health and Social Care, said the government is focused on preventing potential disruption to any categories of medical supplies.

109

109

NY Times

AUGUST 6, 2020

A letter signed by nearly 400 health experts asked the agency to use its vaccine advisory panel when reviewing data on coronavirus trials.

Vaccines 123

Vaccines 123

Outsourcing Pharma

AUGUST 5, 2020

The firms are working to create a platform that gives the ability to monitor temperature-sensitive treatments, vaccines and other products.

Vaccines 119

Vaccines 119

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

AUGUST 4, 2020

New deal with Wockhardt boosts capacity at the crucial 'fill and finish' stage

Vaccines 143

Vaccines 143

pharmaphorum

AUGUST 7, 2020

Pfizer has signed a multi-year agreement with Gilead to manufacture and supply the COVID-19 antiviral remdesivir, which is also being tested in combination with other drugs in an effort to fight the pandemic. Under the terms of the agreement Pfizer will become one of several external partners who manufacture the investigational treatment for the disease.

Immunity 108

Immunity Immunization 108

Pharma Marketing Network

AUGUST 3, 2020

Recently, the Healthcare Businesswomen’s Association (HBA) held a webinar entitled, Virtual Best Practices: Clarity, Collaboration and Connecting , which dove into the topic of “Zoom fatigue,” a new, commonly used term defined by the draining feeling you experience after a day of long, unnecessary meetings. We are all facing new challenges in the rapidly changing work environment.

Communication 94

Communication 94

Pharma Times

AUGUST 3, 2020

Collaboration will explore experimental treatment IMM-101 in combination with other therapies in advanced cancers

119

119

pharmaphorum

AUGUST 4, 2020

New research looks at the factors that speed up and slow down HTA appraisals for rare disease medicines across Europe. Rare diseases drugs have always faced challenges when it comes to HTA approvals, even as governments bring in more regulatory policies that make their path through assessment easier. Several factors make it difficult for HTA bodies often to assess orphan drugs, including a lack of robust trial data due to difficulties in finding patients, the absence of randomised controlled tri

Labelling 104

Labelling 104

Outsourcing Pharma

AUGUST 5, 2020

The bipartisan bill calls for an assessment of the countryâs pharma supply chain, including potential vulnerabilities and impact of foreign manufacturing.

96

96

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

NY Times

AUGUST 4, 2020

Getting medication long meant seeing a licensed provider. Now a strategy for evading Covid-19 makes treatment available via the web.

76

76

Pharma Times

AUGUST 3, 2020

Low-dose and high-dose Cosentyx is effective in rapidly improving skin symptoms and quality of life

123

123

pharmaphorum

AUGUST 4, 2020

Sanofi has been placed under formal investigation in France for possible charges including manslaughter relating to the epilepsy drug Depakine, following the deaths of four babies whose mothers took the drug. Depakine was found to carry a high risk of birth defects if taken by pregnant women. Sanofi , which denies wrongdoing and says it warned of the risks long ago, is already being prosecuted in France following allegations it provided misleading information about the drug.

Communication 104

Communication 104

Outsourcing Pharma

AUGUST 3, 2020

Neurasic Therapeutics is borne from a collaborative effort intended to advance development of opioid-alternative pain relief.

91

91

Pharma in Brief

AUGUST 5, 2020

Summary. On July 24, 2020, the Federal Court dismissed an application for judicial review brought by Natco Pharma (Canada) Inc. ( Natco ) in respect of a July 26, 2019 decision ( Decision ) by the Minister of Health ( Minister ). The Decision refused to accept Natco’s ANDS filing using Gilead Sciences Canada Inc.’s ( Gilead ) product DESCOVY as the Canadian Reference Product.

52

52

Pharma Times

AUGUST 5, 2020

AZ will pay $17m in early milestone payments for the UK biotech’s fibrotic asset

129

129

pharmaphorum

AUGUST 7, 2020

Pharma’s reputation has soared due to the COVID-19 pandemic – but coronavirus is starting to bite companies’ sales. Find out more in our roundup of the biggest R&D, market access and digital stories from the past week. The perception of pharma and medical companies has surged upward since the start of the COVID-19 pandemic, but they still lie mostly outside the top-rated firms in the FutureBrand Index.

Nursing Homes 101

Nursing Homes Vaccines Immunity Immunization 101

Outsourcing Pharma

AUGUST 6, 2020

A leader from the scientific software provider discusses the most challenging obstacles in the pharma supply chain, and solutions that can conquer them.

62

62

Drug Patent Watch

AUGUST 4, 2020

I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities for a Better ROI at the upcoming 13th Portfolio Management & Pipeline Optimization for Generics from September 30th…. The post Finding and Evaluating Market Entry Opportunities for a Better ROI appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

AUGUST 4, 2020

Drug approved to treat major depressive disorder with acute suicidal ideation or behaviour

118

118

pharmaphorum

AUGUST 5, 2020

The UK digital mental health support platform Kooth has joined with five of the UK’s well known Instagram influencers to launch a campaign to help students deal with the pressures of exam results season. The campaign encourages the hundreds of thousands of students waiting to receive their exam results, to stay mentally strong and know they have access to support, if needed.

99

99

Outsourcing Pharma

AUGUST 6, 2020

The agency continues to provide resources for the life-sciences industry, approve tests, and take action against companies offering false treatments.

59

59

Drug Channels

AUGUST 7, 2020

Today’s guest post comes from Rob Brown, VP/GM of RxCrossroads by McKesson Program Pharmacy. Rob reviews how COVID-19 is changing patient access and adherence to specialty therapies. He then describes specific RxCrossroads’ program changes that are helping patients and providers remain on therapy and navigate this challenging environment. To learn more, visit www.McKesson.com/RxCrossroads.

40

40

Pharma Times

AUGUST 4, 2020

Therapy has been approved to treat advanced NTRK fusion-positive solid tumours

124

124

pharmaphorum

AUGUST 7, 2020

Biogen has bought a licence to co-develop and co-market potential Parkinson’s disease drugs with US biotech Denali, in a deal worth more than $2.1 billion. Denali has been working on small-molecule compounds capable of crossing the blood-brain barrier and Biogen has bought a licence to co-develop and co-market compounds known as LRRK2 inhibitors in Parkinson’s disease.

Compounding 67

Compounding 67

Outsourcing Pharma

AUGUST 6, 2020

A leader from IBM Watson Health talks about how its advanced EDC solution is geared toward helping studies save precious time and conserve costs.

59

59

Pharmacy Joe

AUGUST 5, 2020

In this episode, I’ll discuss the dose of inhaled tranexamic acid used for nonmassive hemoptysis. Episode 528: What dose of inhaled tranexamic acid is used for nonmassive hemoptysis? Subscribe on iTunes , Android , or Stitcher Tranexamic acid (TA) is an antifibrinolytic medication. It forms a reversible complex that displaces plasminogen from fibrin resulting in inhibition of fibrinolysis.

Inpatient 40

Inpatient Labelling Hospitals 40

Pharma Times

AUGUST 3, 2020

Subcutaneous formulation of Darzalex in combination with pomalidomide and dexamethasone meets primary endpoint

105

105

pharmaphorum

AUGUST 7, 2020

Health technology firms Cerner and LRVHealth have invested $6 million in Xealth to scale up its business offering digital health tools to patients and clinicians. The companies said the new relationship aims to give patients control over their own digital data so they can be more engaged in their treatment plans. Cerner and LRVHealth join Xealth’s other investors Atrium Health, Cleveland Clinic, Froedtert and the Medical College of Wisconsin, MemorialCare Innovation Fund, Providence Ventures and

Cerner 57

Cerner 57

Outsourcing Pharma

AUGUST 5, 2020

Initial information from the life-sciences specialistâs pilot program shows potential pathways to solving common pharma supply chain challenges.

59

59

Med Ed 101

AUGUST 5, 2020

While not incredibly common, medications can cause dysregulation of our body’s thermoregulation process and cause a rise in core temperature in the presence of normal core body temperature which leads to hyperthermia. Before we get to the drugs that cause hyperthermia, let’s review thermoregulation. Our body is able to regulate our core temperature to keep […].

40

40

Pharma Times

AUGUST 7, 2020

Study co-led by UCL and the London School of Hygiene & Tropical Medicine

123

123

pharmaphorum

AUGUST 5, 2020

The perception of pharma and medical product companies has surged forward since the start of the COVID-19 pandemic, but they still lie mostly outside the top-rated firms in the FutureBrand Index. Roche, AstraZeneca, Novo Nordisk, and Sanofi all shot up the rankings in the first edition of the report since the start of the coronavirus crisis, but the big loser was Gilead Sciences, falling 71 places to 74 in the list since the last edition in 2018.

57

57

Outsourcing Pharma

AUGUST 5, 2020

An executive from Pharmaceutical Associates Inc. believes bringing drug manufacturing back to the country will help avoid shortages and other disasters.

55

55

Drug Channels

AUGUST 4, 2020

Last Friday’s Executive Orders revived the government’s effort to reform rebates in federal programs. Whether that effort succeeds, today's update reminds us what's still at stake in reforming rebates within the U.S. drug channel. For 2019, Drug Channels Institute estimates that the gross-to-net bubble —the dollar gap between sales at brand-name drugs' list prices and their sales at net prices after rebates and other reductions—reached $175 billion.

Drug Pricing 52

Drug Pricing 52